FASLG and autoimmune polyendocrinopathy: Hydroxychloroquine (HCQ) has also been shown to be protective against thrombosis in aPL-positive patients [23], and as in our patient, it may be reasonable to recommend HCQ for thrombosis prevention in APS as an add-on or alternative treatment option in cases resistant to other treatment modalities.